Tarn Biosciences
East Lansing
About Tarn Biosciences
Tarn Biosciences develops a suite of therapeutics for the treatment of tuberculosis.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Funding stage: Seed
- Last round: Pre-Seed (Jun 2021)
- Website: tarnbio.com
Industries & Categories
Biopharma, Biotechnology, Health Care, Health Diagnostics, Medical
Canonical: https://fsome.com/organization/tarn-biosciences-2738536 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.